Epigral Board of Directors
Get the latest insights into the leadership at Epigral. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Gaurang Trivedi | Company Secretary & Compliance Officer |
| Maulik Patel | Chairman & Managing Director |
| Kaushal Soparkar | Executive Director |
| Karana Patel | Non Independent & Non Executive Director |
| Ankit Patel | Non Independent & Non Executive Director |
| Darshan Patel | Non Independent & Non Executive Director |
| Manubhai Patel | Non Executive Independent Director |
| Sanjay Asher | Non Executive Independent Director |
| Kanubhai Patel | Non Executive Independent Director |
| Raju Swamy | Non Executive Independent Director |
| Priyanka Chopra | Non Executive Independent Woman Director |
Epigral FAQs
The board at Epigral consists of experienced professionals, including Gaurang Trivedi, Maulik Patel, and others, overseeing the company’s strategic and corporate governance.
Directors at Epigral are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Gaurang Trivedi is the current chairman at Epigral.
Executive directors at Epigral are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Epigral adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Epigral, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
